Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
clinical trials
fda
3
×
life sciences
national blog main
alexion pharmaceuticals
boston
deals
national top stories
3b pharmaceuticals
abeona therapeutics
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alkermes
allan kaspar
alnylam pharmaceuticals
altria
amgen
amphivena therapeutics
amryt pharma
amyotrophic lateral sclerosis (als)
andrew komjathy
aron knickerbocker
artara therapeutics
autoimmune disorders
avexis
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
brian johns
brian kaspar
cancer drugs
cancer immunotherapy
catabasis pharmaceuticals
centers for disease control and prevention
What
disease
3
×
drug
medicines
pharma
pharmaceuticals
according
akcea
alternative
autoimmune
biotech
candidate
cases
caught
causing
centers
cigarettes
control
deal
deaths
dicerna
electronic
expensive
eye
gene
hepatitis
including
injuries
intended
lead
linked
lung
nash
news
pay
potential
prevention
producing
protein
ra
research
Language
unset
3
×
Current search:
fda
×
disease
×
" boston blog main "
×
unset
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More